- Taste and Smell Disturbances in Patients with Gastroparesis and Gastroesophageal Reflux Disease
-
Kabadi A, Saadi M, Schey R, Parkman HP
- KMID: 2387827
- J Neurogastroenterol Motil.
- 2017 Jul;23(3):370-377.
- doi: 10.5056/jnm16132
BACKGROUND/AIMS: Patients with gastroparesis and gastroesophageal reflux disease (GERD) often report decreased enjoyment when eating. Some patients remark that food does not smell or taste the same. To determine if... -
- CITED
-
- Close
- SHARE
-
- Close
- Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study
-
Midani D, Parkman HP
- KMID: 2433457
- J Neurogastroenterol Motil.
- 2016 Oct;22(4):650-655.
- doi: 10.5056/jnm15203
BACKGROUND/AIMS: Serotonin receptor (eg, 5-HT₃) antagonists are used to treat nausea and vomiting from a variety of causes. Granisetron transdermal system (GTS) is an appealing delivery system for patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Distal Esophageal Impedance Measured by High-resolution Esophageal Manometry With Impedance Suggests the Presence of Barrett’s Esophagus
-
Kataria R, Rosenfeld B, Malik Z, Harrison M, Smith MS, Schey R, Parkman HP
- KMID: 2504002
- J Neurogastroenterol Motil.
- 2020 Jul;26(3):344-351.
- doi: 10.5056/jnm19105
Background/Aims Barrett’s esophagus (BE) is characterized by intestinal metaplasia in the distal esophagus. The aims of this study are to: (1) Compare baseline distal esophageal impedance (DEI) using high-resolution esophageal... -
- CITED
-
- Close
- SHARE
-
- Close
